High-K materials and metal gates for CMOS applications
Robertson, John, Wallace, Robert M.
Published in Materials science & engineering. R, Reports : a review journal (01.02.2015)
Published in Materials science & engineering. R, Reports : a review journal (01.02.2015)
Get full text
Journal Article
Fulvestrant 500 mg versus anastrozole 1 mg for hormone receptor-positive advanced breast cancer (FALCON): an international, randomised, double-blind, phase 3 trial
Robertson, John F R, Prof, Bondarenko, Igor M, Prof, Trishkina, Ekaterina, PhD, Dvorkin, Mikhail, MD, Panasci, Lawrence, Prof, Manikhas, Alexey, MD, Shparyk, Yaroslav, PhD, Cardona-Huerta, Servando, PhD, Cheung, Kwok-Leung, MD, Philco-Salas, Manuel Jesus, MD, Ruiz-Borrego, Manuel, MD, Shao, Zhimin, Prof, Noguchi, Shinzaburo, Prof, Rowbottom, Jacqui, MSc, Stuart, Mary, MD, Grinsted, Lynda M, MSc, Fazal, Mehdi, MD, Ellis, Matthew J, Prof
Published in The Lancet (British edition) (17.12.2016)
Published in The Lancet (British edition) (17.12.2016)
Get full text
Journal Article
Audit of the autoantibody test, EarlyCDT® -Lung, in 1600 patients: An evaluation of its performance in routine clinical practice
Jett, James R, Peek, Laura J, Fredericks, Lynn, Jewell, William, Pingleton, William W, Robertson, John F.R
Published in Lung cancer (Amsterdam, Netherlands) (01.01.2014)
Published in Lung cancer (Amsterdam, Netherlands) (01.01.2014)
Get full text
Journal Article
Fulvestrant 500 mg Versus Anastrozole 1 mg for the First-Line Treatment of Advanced Breast Cancer: Overall Survival Analysis From the Phase II FIRST Study
Ellis, Matthew J, Llombart-Cussac, Antonio, Feltl, David, Dewar, John A, Jasiówka, Marek, Hewson, Nicola, Rukazenkov, Yuri, Robertson, John F R
Published in Journal of clinical oncology (10.11.2015)
Published in Journal of clinical oncology (10.11.2015)
Get full text
Journal Article
Meta-analyses of phase 3 randomised controlled trials of third generation aromatase inhibitors versus tamoxifen as first-line endocrine therapy in postmenopausal women with hormone receptor-positive advanced breast cancer
Robertson, John. F.R., Paridaens, Robert J., Lichfield, Jasmine, Bradbury, Ian, Campbell, Christine
Published in European journal of cancer (1990) (01.03.2021)
Published in European journal of cancer (1990) (01.03.2021)
Get full text
Journal Article
Delayed second dose of the BNT162b2 vaccine: innovation or misguided conjecture?
Robertson, John F R, Sewell, Herb F, Stewart, Marcia
Published in The Lancet (British edition) (06.03.2021)
Published in The Lancet (British edition) (06.03.2021)
Get full text
Journal Article
Calculation of TiO2 Surface and Subsurface Oxygen Vacancy by the Screened Exchange Functional
Li, Hongfei, Guo, Yuzheng, Robertson, John
Published in Journal of physical chemistry. C (13.08.2015)
Published in Journal of physical chemistry. C (13.08.2015)
Get full text
Journal Article
3D Behavior of Schottky Barriers of 2D Transition-Metal Dichalcogenides
Guo, Yuzheng, Liu, Dameng, Robertson, John
Published in ACS applied materials & interfaces (25.11.2015)
Published in ACS applied materials & interfaces (25.11.2015)
Get full text
Journal Article
ESR1 Mutations and Overall Survival on Fulvestrant versus Exemestane in Advanced Hormone Receptor-Positive Breast Cancer: A Combined Analysis of the Phase III SoFEA and EFECT Trials
Turner, Nicholas C, Swift, Claire, Kilburn, Lucy, Fribbens, Charlotte, Beaney, Matthew, Garcia-Murillas, Isaac, Budzar, Aman U, Robertson, John F R, Gradishar, William, Piccart, Martine, Schiavon, Gaia, Bliss, Judith M, Dowsett, Mitch, Johnston, Stephen R D, Chia, Stephen K
Published in Clinical cancer research (01.10.2020)
Published in Clinical cancer research (01.10.2020)
Get full text
Journal Article
Mechanochemical destruction of halogenated organic pollutants: A critical review
Cagnetta, Giovanni, Robertson, John, Huang, Jun, Zhang, Kunlun, Yu, Gang
Published in Journal of hazardous materials (05.08.2016)
Published in Journal of hazardous materials (05.08.2016)
Get full text
Journal Article
Activity of Fulvestrant 500 mg Versus Anastrozole 1 mg As First-Line Treatment for Advanced Breast Cancer: Results From the FIRST Study
ROBERTSON, John F. R, LLOMBART-CUSSAC, Antonio, ROLSKI, Janusz, FELTL, David, DEWAR, John, MACPHERSON, Euan, LINDEMANN, Justin, ELLIS, Matthew J
Published in Journal of clinical oncology (20.09.2009)
Published in Journal of clinical oncology (20.09.2009)
Get full text
Journal Article
Double-Blind, Randomized Placebo Controlled Trial of Fulvestrant Compared With Exemestane After Prior Nonsteroidal Aromatase Inhibitor Therapy in Postmenopausal Women With Hormone Receptor–Positive, Advanced Breast Cancer: Results From EFECT
CHIA, Stephen, GRADISHAR, William, BRUFSKY, Adam, POSSINGER, Kurt, RENNIE, Pamela, SAPUNAR, Francisco, LOWE, Elizabeth, PICCART, Martine, MAURIAC, Louis, BINES, Jose, AMANT, Frederic, FEDERICO, Miriam, FEIN, Luis, ROMIEU, Gilles, BUZDAR, Aman, ROBERTSON, John F. R
Published in Journal of clinical oncology (01.04.2008)
Published in Journal of clinical oncology (01.04.2008)
Get full text
Journal Article